Showing results (31-40 of 53) with videos related to
Sort By:
Pageof 6
Scientific Reports|March 10, 2019
Cross-disease analysis of Alzheimer's disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseasesLaura Caberlotto, T-Phuong Nguyen, Mario Lauria, et al.Addiction Biology|October 25, 2011
Brain reinforcement system function is ghrelin dependent: studies in the rat using pharmacological fMRI and intracranial self-stimulationPaul J Wellman, P Shane Clifford, Juan A Rodriguez, et al.Plos One|February 11, 2011
Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonistsAlessandro Gozzi, Giuliano Turrini, Laura Piccoli, et al.International Journal of Molecular Sciences|September 14, 2024
Comparison between USPIOs and SPIOs for Multimodal Imaging of Extracellular Vesicles Extracted from Adipose Tissue-Derived Adult Stem CellsArnaud M Capuzzo, Giusi Piccolantonio, Alessandro Negri, et al.Neuroendocrinology|July 23, 2011
GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogsVivian J A Costantini, Elena Vicentini, Fabio M Sabbatini, et al.Journal of Medicinal Chemistry|May 11, 2017
Atropisomerism and Conformational Equilibria: Impact on PI3Kδ Inhibition of 2-((6-Amino-9H-purin-9-yl)methyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one (IC87114) and Its Conformationally Restricted AnalogsAlessio Lodola, Serena Bertolini, Matteo Biagetti, et al.The Journal of Biological Chemistry|May 25, 2006
Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activationAdelheid L Roth, Erika Marzola, Anna Rizzi, et al.Bioorganic & Medicinal Chemistry|January 20, 2022
Discovery of Pyrazolo[1,5-a]pyrazin-4-ones as Potent and Brain Penetrant GluN2A-Selective Positive Allosteric Modulators Reducing AMPA Receptor Binding ActivityFumie Sakurai, Takafumi Yukawa, Asato Kina, et al.Bioorganic & Medicinal Chemistry|January 14, 2023
Design and synthesis of 6-methylpyridin-2-one derivatives as novel and potent GluN2A positive allosteric modulators for the treatment of cognitive impairmentTakafumi Yukawa, Tohru Yamashita, Toshihiro Imaeda, et al.Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK(1) receptor antagonistsFabio M Sabbatini, Romano Di Fabio, Cristiana Griffante, et al.Pageof 6